PATENT CLAIM ANALYSIS

Application Number: 16192598
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "085100"]

Abstract:
Provided are drug delivery compositions and devices useful for the treatment and/or prevention of cancer and metastatic tumors. For example, a drug delivery device is provided that comprises a biodegradable scaffold carrying one or more anti-cancer therapeutic agents that activate the innate immune system (e.g., STING agonists) and/or the adaptive immune system (e.g., anti-PD-1 antibodies). The compositions and devices may include a cytokine (e.g., IL-15 superagonist). The drug delivery device can be implanted in the void volume of a resected tumor to prevent tumor regrowth and tumor metastasis. Also provided are methods of making the drug delivery compositions and devices as well as kits containing materials to provide the compositions and devices.

Claim (Index 150):
The method of  claim 145 , wherein the biomaterial is or comprises a hydrogel.

Metadata:
- Claim Count in Document: 467.0
- Percentile: 98.0
- Lexical Diversity: 1.69333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16192663', '15565609', '15553222', '15303985', '14280667']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.558081791410897
- 35 USC 102 Novelty (BERT): 0.6113723297065833
- Combined Prediction Score: 0.5634108452404656
- Mean Citation Score: 328.200062
- Max Citation Score: 608.0384
- Similarity Product: 443.8282862190247

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test